Background. Atherothrombotic disease, including coronary artery disease (CAD) and
peripheral artery disease (PAD), can lead to cardiovascular (CV) events, such as myocardial …

Peripheral artery disease affects> 200 million people worldwide and is associated with
significant limb and cardiovascular morbidity and mortality. Limb revascularization is …

The European Society of Vascular Medicine (ESVM) was founded in Paris in 2012 as a
confederation of already existing and emerging European societies of vascular medicine. At …

Objectives The aims of this population based study were to describe mid-to long-term
amputation risk, cumulative incidence of death or amputation, and differences in pre …

BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …

Objective The aim of this study was to determine sex specific differences in the invasive
treatment of symptomatic peripheral arterial occlusive disease (PAOD) between member …

Objective The aim was to determine long-term mortality rates and the underlying cause of
death for subjects with different peripheral arterial disease (PAD) stages in a population …

Background Long-term cardiovascular and limb outcomes after revascularization for
peripheral artery disease and, in particular, prognosis after post-procedure major adverse …

Background Peripheral arterial disease (PAD) is known to be associated with high
cardiovascular risk, but the individual impact of PAD presentations on risk of macrovascular …

Background: Revascularization is important for symptom treatment and limb salvage in
peripheral artery disease, yet little data exist on the incidence of post-procedure major …